Novo Nordisk A/S (NYSE:NVO – Free Report) – Equities research analysts at Erste Group Bank lifted their FY2026 earnings estimates for shares of Novo Nordisk A/S in a research report issued to clients and investors on Wednesday, August 5th. The consensus estimate for Novo Nordisk A/S’s current full-year earnings is $3.39 per share. Get Novo Nordisk A/S alerts:Several other analysts have also recently issued reports on NVO. Institutional Investors Weigh In On Novo Nordisk A/SSeveral hedge funds and other institutional investors have recently modified their holdings of NVO. Featured StoriesReceive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.